KBC Equity Fund Pharma C
| MVD-Fonds Rating | EDA |
|---|---|
 | - |
ISIN: BE0166584350 | WKN: 633868
KAG: KBC AM NV
NAV: 2.368,36 EUR am 12.05.2022
Portfolio
Watchlist
KursalarmChart
Kennzahlen KBC Equity Fund Pharma C
| 1M | 6M | 1J | 3J | 5J | 10J | Beginn | |
| Performance | -6,78% | -3,56% | +18,18% | +50,42% | +60,80% | +244,43% | +377,70% |
| Volatilität | +18,74% | +16,42% | +13,88% | +18,36% | +16,49% | +15,58% | +17,08% |
| Sharpe Ratio | -3,04 | -0,41 | +1,34 | +0,82 | +0,63 | +0,87 | +0,41 |
| Bester Monat | - | +6,55% | +6,64% | +11,33% | +11,33% | +11,33% | +11,33% |
| Schl. Monat | - | -8,91% | -8,91% | -8,91% | -10,35% | -10,35% | -12,15% |
| Max. Verlust | -8,68% | -13,15% | -13,15% | -28,06% | -28,06% | -28,06% | -60,14% |
Monatsperformance KBC Equity Fund Pharma C
| 2022 | 2021 | 2020 | 2019 | 2018 | |
| Januar | -8,91% | +4,17% | -0,50% | +9,54% | +2,43% |
| Februar | -1,04% | -2,42% | -5,95% | +2,97% | -3,63% |
| März | +5,44% | +5,48% | -4,31% | +2,65% | -2,87% |
| April | +0,65% | +2,03% | +11,33% | -1,85% | +3,25% |
| Mai | -3,87% | +1,13% | +2,14% | -1,57% | +5,59% |
| Juni | - | +6,64% | -1,47% | +4,11% | +1,50% |
| Juli | - | +4,04% | -1,69% | +1,48% | +6,18% |
| August | - | +3,23% | +0,96% | +0,70% | +3,78% |
| September | - | -2,72% | +0,46% | -0,38% | +0,80% |
| Oktober | - | +6,34% | -4,84% | +1,97% | -4,82% |
| November | - | -0,29% | +5,54% | +6,02% | +3,56% |
| Dezember | - | +6,55% | -0,41% | +1,46% | -10,35% |
| Gesamt | -8,04% | +39,26% | +0,06% | +30,04% | +4,14% |
Diese Fonds könnten Sie auch interessieren
Vergleichen Sie diese Fonds mit Ihrem ausgewähltem Fonds (KBC Equity Fund Pharma) oder suchen Sie weitere Top-Fonds zum Thema Aktien (Branche Gesundheit/Pharma) weltweit in EUR:
Fonds vergleichenWeitere ähnliche Fonds